<!--https://www.openaustralia.org.au/senate/?id=2015-11-30.114.1-->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
 <head>
  <meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
  <title>
   HIV-AIDS: 30 Nov 2015: Senate debates (OpenAustralia.org)
  </title>
  <meta content="Making parliament easy." name="description"/>
  <meta content="Parliament, government, House of Representatives, Senate, Senator, MP, Member of Parliament, MPs, Australia, Australian, HIV-AIDS: 30 Nov 2015" name="keywords"/>
  <meta content="5FBaCDi8kCKdo4s64NEdB5EOJDNc310SwcLLYHmEbgg=" name="verify-v1"/>
  <meta content="width=device-width; initial-scale=1.0; maximum-scale=1.0" name="viewport">
   <link href="mailto:contact@openaustralia.org" rel="author" title="Send feedback"/>
   <link href="http://www.openaustralia.org.au/" rel="home" title="Home"/>
   <link href="/" rel="start" title="Home"/>
   <!-- skin: mobile -->
   <link href="/style/default/global_non_ns4_mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/print.css" media="print" rel="stylesheet" type="text/css"/>
   <script type="text/javascript">
    var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
   </script>
   <script type="text/javascript">
    var pageTracker = _gat._getTracker("UA-3107958-3");
pageTracker._initData();
pageTracker._trackPageview();
   </script>
  </meta>
 </head>
 <body>
  <div id="container">
   <a name="top">
   </a>
   <div id="banner">
    <div id="title">
     <h1>
      <a href="/" title="To the front page of the site">
       <img alt="OpenAustralia.org beta" height="32" src="/images/openaustraliaorgbeta.gif" width="262"/>
      </a>
     </h1>
    </div>
   </div>
   <!-- end #banner -->
   <div id="content">
    <div class="stripe-head-1">
     <div class="main">
      <h2>
       Senate debates
      </h2>
      <h3>
       Monday, 30 November 2015
      </h3>
      <h4>
       Motions
      </h4>
      <h5>
       HIV-AIDS
      </h5>
      <p>
       3:41 pm
      </p>
      <a name="g114.2">
      </a>
      <p class="speaker">
       <a href="/senator/?m=100848" title="See more information about Robert Simms">
        <img alt="Photo of Robert Simms" class="portrait" src="/images/mps/10842.jpg"/>
        <strong>
         Robert Simms
        </strong>
       </a>
       <small>
        (Australian Greens) |
        <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansards,hansards80%20Date%3A30%2F11%2F2015;rec=0;resCount=Default" title="The source of this piece of text">
         Hansard source
        </a>
       </small>
       <p>
        I move:
       </p>
       <p class="italic">
        That the Senateâ€”
       </p>
       <p class="italic">
        (a) notes that:
       </p>
       <p class="italic">
        (i) the
        <a href="http://en.wikipedia.org/wiki/Council_of_Australian_Governments" rel="nofollow">
         Council of Australian Governments
        </a>
        has agreed to a target to end new
        <a href="http://en.wikipedia.org/wiki/HIV" rel="nofollow">
         HIV
        </a>
        infections in Australia by 2020,
       </p>
       <p class="italic">
        (ii) in 2014, there were 1 080 infections in Australia with about 750 of these amongst sex between men,
       </p>
       <p class="italic">
        (iii) each new infection and lifelong treatment brings significant health and personal impacts, with lifelong costs estimated at $200 000 to $300 000 per person,
       </p>
       <p class="italic">
        (iv) there is now a strong evidence base and consensus amongst Australian non government organisations in this area that pre exposure prophylaxis (PrEP) along with rapid HIV tests and home self-tests are vital to add to the prevention tools currently available, and
       </p>
       <p class="italic">
        (v) France is the latest jurisdiction to announce wide scale access to PrEP, with many other cities and states already having arrangements in place; and
       </p>
       <p class="italic">
        (b) calls on the Government to:
       </p>
       <p class="italic">
        (i) demonstrate leadership on HIV by urgently removing regulatory barriers to access to PrEP, rapid HIV tests and home self-tests, and
       </p>
       <p class="italic">
        (ii) as an interim measure, urgently explore policy options, including expanded trials in states and territories, to enable access to these important prevention tools.
       </p>
       <a name="g115.1">
       </a>
       <p class="speaker">
        <a href="/senator/?m=100260" title="See more information about Scott Ryan">
         <img alt="Photo of Scott Ryan" class="portrait" src="/images/mps/10715.jpg"/>
         <strong>
          Scott Ryan
         </strong>
        </a>
        <small>
         (Liberal Party, Assistant Cabinet Secretary) |
         <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansards,hansards80%20Date%3A30%2F11%2F2015;rec=0;resCount=Default" title="The source of this piece of text">
          Hansard source
         </a>
        </small>
        <p>
         I seek leave to make a short statement.
        </p>
        <a name="g115.3">
        </a>
        <p class="speaker">
         <a href="/senator/?m=100839" title="See more information about Gavin Marshall">
          <img alt="Photo of Gavin Marshall" class="portrait" src="/images/mps/10419.jpg"/>
          <strong>
           Gavin Marshall
          </strong>
         </a>
         <small>
          (Deputy-President) |
          <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansards,hansards80%20Date%3A30%2F11%2F2015;rec=0;resCount=Default" title="The source of this piece of text">
           Hansard source
          </a>
         </small>
         <p>
          Leave is granted for one minute.
         </p>
         <a name="g115.4">
         </a>
         <p class="speaker">
          <a href="/senator/?m=100260" title="See more information about Scott Ryan">
           <img alt="Photo of Scott Ryan" class="portrait" src="/images/mps/10715.jpg"/>
           <strong>
            Scott Ryan
           </strong>
          </a>
          <small>
           (Liberal Party, Assistant Cabinet Secretary) |
           <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansards,hansards80%20Date%3A30%2F11%2F2015;rec=0;resCount=Default" title="The source of this piece of text">
            Hansard source
           </a>
          </small>
          <p>
           The Australian government is committed to the prevention, testing and treatment of
           <a href="http://en.wikipedia.org/wiki/HIV" rel="nofollow">
            HIV
           </a>
           in Australia and delivering on the actions and objections of the Seventh National HIV Strategy 2014-2017. To extend the use of a medicine already registered on the Australian register of therapeutic goods to include additional clinical indications such as for pre-exposure prophylactic use, it is necessary for the sponsor of that product to submit an application to the
           <a href="http://en.wikipedia.org/wiki/Therapeutic_Goods_Administration" rel="nofollow">
            Therapeutic Goods Administration
           </a>
           . Neither the TGA nor the Australian government is able to compel a sponsor to submit such an application. There are demonstration and trial projects underway in several states that will provide an important evidence base with which to discuss and draft a national policy regarding pre-exposure prophylactic use.
          </p>
          <p>
           Question agreed to.
          </p>
          <br/>
          <br/>
          <br/>
          <br/>
          <div id="footer">
           <p>
            <a href="/?show_pc">
             View the PC OA website
            </a>
           </p>
          </div>
         </p>
        </p>
       </p>
      </p>
     </div>
    </div>
   </div>
  </div>
 </body>
</html>
